HH
Headlands Holdco, LLC
SEC filingBiotechnology · Boston, MA
Amount raised$3.1Msold at filing
Total offering$3.1M
Investors in the raise1count reported to the SEC
FiledJul 15, 2026first sale Jun 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Megan Matthew PreinerDirector
Kyle Matthew BurtnettDirector
Joshua Matthew NelsonExecutive Officer, Director
Peter Matthew McLellandDirector
Executive officers, directors and promoters as listed on the Form D.